egtazic acid has been researched along with E coli Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, J; Liu, F; Sadler, JE | 1 |
| Phillips, R; Roberts, AP | 1 |
| Dytoc, M; Fedorko, L; Sherman, PM | 1 |
| Clas, F; Loos, M; Schmidt, G | 1 |
4 other study(ies) available for egtazic acid and E coli Infections
| Article | Year |
|---|---|
Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.
Topics: Animals; Calcium; Cyclic AMP-Dependent Protein Kinases; Diarrhea; Egtazic Acid; Endothelial Cells; Escherichia coli; Escherichia coli Infections; Gene Silencing; Hemolytic-Uremic Syndrome; Humans; Mice; Protein Binding; Protein Kinase C-alpha; Protein Kinase Inhibitors; RNA, Small Interfering; Shiga Toxin 1; Shiga Toxin 2; Signal Transduction; Trihexosylceramides; Umbilical Veins; von Willebrand Factor | 2011 |
The relative importance of the classical and alternative complement pathways in serum bactericidal activity against Escherichia coli.
Topics: Complement System Proteins; Egtazic Acid; Escherichia coli; Escherichia coli Infections; Hot Temperature; Humans | 1983 |
Signal transduction in human epithelial cells infected with attaching and effacing Escherichia coli in vitro.
Topics: Bacterial Adhesion; Calcium; Cell Line; Egtazic Acid; Epithelial Cells; Epithelium; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Microscopy, Electron; Oxalates; Phenotype; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Signal Transduction; Spectrometry, Fluorescence | 1994 |
The role of the classical pathway for the bactericidal effect of normal sera against gram-negative bacteria.
Topics: Animals; Complement Activating Enzymes; Complement Activation; Complement C1; Complement C1q; Complement Pathway, Classical; Edetic Acid; Egtazic Acid; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Guinea Pigs; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipopolysaccharides; Salmonella | 1985 |